Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral…
Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension and 1 more
- Published
- 31 Dec 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Presence of particulate matter: potential presence of metal particulates in the product.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
- Brand / company
- Merck Sharp & Dohme LLC
- Codes / lots
- Lot #: Z014503, Exp 11/15/2027 | Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 31 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.